India’s drugmakers see limited gains from the minimum import price policy as weak demand, stockpiling, and slow buyer shifts delay the impact on domestic pharma manufacturing.
The Shigella threat in Kerala continues to grow as the state reported one more death linked to the infection along with seven fresh cases from multiple districts.
.jpeg)
India’s generic cancer drug market is expanding with improved affordability, innovation, and access, as companies like Alembic advance complex oncology generics globally.
Gujarat’s Sickle Cell Mission has emerged as one of India’s most successful public health initiatives, with the state crossing 1.11 crore screenings for sickle cell disease.
Midjourney, the AI image-generation startup known for creating digital art, is making an unexpected move into healthcare.
Glenmark's drug launch could be a game changer as it expands its presence in the high-value rare disease segment.
The bowel disease treatment race is gaining momentum after Spyre Therapeutics reported positive results from a mid-stage clinical trial of its experimental ulcerative colitis drug, SPY002.
.jpeg)
A copper-based drug shows potential in reducing toxic proteins and improving cognition in Alzheimer’s, offering a new approach targeting brain waste clearance mechanisms.
HLL rolls out AMRIT Plus, a premium pharmacy chain as the government-owned healthcare company expands its presence in India's healthcare sector. HLL Lifecare has launched AMRIT Plus, a premium pharmacy chain designed to offer medicines, wellness...
Jharkhand is building a multi-stakeholder model to end TB as the state government sets an ambitious target to eliminate tuberculosis by 2029. The announcement was made by Health Minister Irfan Ansari during a National Task Force meeting under...
, CDSCO.jpg)